risks of microdosing glp 1 Why GLP-1 Microdosing? A Closer Look at Reported Benefits GLP-1 microdoses go mainstream with

Sekizkardes H, Chung ST, Chacko S et al (2020) Free fatty acid processing diverges in human pathologic insulin resistance conditions

After 2 hours of incubation, floating cells were removed by washing with PBS and adherent macrophages were treated with or without 100 ng/mL LPS for 6 hours

Gonlachanvit S, Chen YH, Hasler WL, et al

Most patients report noticeable appetite reduction and initial weight changes within 2-4 weeks of starting GLP-1 therapy, though measurable fat loss typically accelerates after 8-12 weeks at therapeutic doses

Although there is little literature on the role that -arrestin 2 plays in GLP-1R internalization and desensitization, there is some evidence that these processes can occur independently of -arrestin recruitment, in a clathrin-independent mechanism